Skip to content
Axcess News – Lifestyle
Author:
AMGEN
AMGEN TO PRESENT AT THE EUROPEAN SOCIETY OF MEDICAL ONCOLOGY CONGRESS 2026
October 20, 2026
TEZSPIRE® DELIVERED HISTOLOGIC REMISSION AND SYMPTOM IMPROVEMENT IN EOSINOPHILIC ESOPHAGITIS
October 20, 2026
AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR DAZODALIBEP IN MODERATE-TO-SEVERE SYSTEMIC SJÖGREN’S DISEASE
September 22, 2026
FDA APPROVES REDUCED MONITORING TIME FOR FIRST TWO DOSES OF IMDELLTRA®
September 14, 2026
AMGEN TO PRESENT AT THE MORGAN STANLEY 24TH ANNUAL GLOBAL HEALTHCARE CONFERENCE
September 9, 2026
IMDELLTRA + IMFINZI Show OS Improvement in ES-SCLC
September 8, 2026
AMGEN TO PRESENT AT THE 2026 WELLS FARGO HEALTHCARE CONFERENCE
September 2, 2026
AMGEN’S REPATHA® REDUCES RISK OF DEATH IN PATIENTS AT HIGH RISK FOR A FIRST HEART ATTACK OR STROKE
August 31, 2026
AMGEN REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS
August 4, 2026
AMGEN ANNOUNCES 2026 THIRD QUARTER DIVIDEND
July 30, 2026
1
2
3
Next Page
→